PubMed Health⌕ Search

PubMed · 5640189

Individual normal laboratory values. Preliminary observations.

Abstract

A brief and preliminary outline is given describing a consecutive and continuing study of laboratory blood values of only 12 of 48 "normal healthy" subjects with only a few values given. The major emphasis is that of obtaining blood from each subject over a 12-week period to be repeated annually in order to determine individual values and in obtaining a chemical identification of each subject with the anticipation that more information will be available concerning the meaning and limiting parameters of "normal" biologic values. Such a study is made available through the application of modern advances in automation and the wide use of computers. It seems likely that some disorders can be discovered before clinically apparent, with the hope that consequent preventive measures and therapy may be more effective. The few values presented represent only a small part of those yet to be obtained. Much more work is needed in this study of normal values whose parameters must be further defined.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F J Glassy, C M Blumenfeld. 1968. Individual normal laboratory values. Preliminary observations.. https://pubmed.ncbi.nlm.nih.gov/5640189/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS.

Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) is the precursor of Delta9-tetrahydrocannabinol (Delta9-THC) in hemp plants. During smoking, the non-psychoactive Delta9-THCA-A is converted to Delta9-THC, the main psychoactive component of marihuana and hashish. Although the decarboxylation of Delta9-THCA-A to Delta9-THC was assumed to be complete--which means that no Delta9-THCA-A should be detectable in urine and blood serum of cannabis consumers--we found Delta9-THCA-A in the urine and blood serum samples collected from police controls of drivers suspected for driving under the influence of drugs (DUID). For LC-MS/MS analysis, urine and blood serum samples were prepared by solid-phase extraction. Analysis was performed with a phenylhexyl column using gradient elution with acetonitrile. For detection of Delta9-THCA-A, the mass spectrometer (MS) (SCIEX API 365 triple-quadrupole MS with TurboIonSpray source) was operated in the multiple reaction monitoring (MRM) mode using the following transitions: m/z357 --> 313, m/z357 --> 245 and m/z357 --> 191. Delta9-THCA-A could be detected in the urine and blood serum samples of several cannabis consumers in concentrations of up to 10.8 ng/ml in urine and 14.8 ng/ml in serum. The concentration of Delta9-THCA-A was below the Delta9-THC concentration in most serum samples, resulting in molar ratios of Delta9-THCA-A/Delta9-THC of approximately 5.0-18.6%. Only in one case, where a short elapsed time between the last intake and blood sampling is assumed, the molar ratio was 18.6% in the serum. This indicates differences in elimination kinetics, which need to be investigated in detail.

Blood Chemical Analysis↗